Pharmion
Boulder
About Pharmion
Pharmion is a global biotech company that is dedicated to the hematology and oncology communities. We work in partnership with a network of scientific and clinical advisors to identify and develop products for global hematology and oncology markets. To expand each product's potential, we have established our own regulatory, development and sales and marketing organizations in the United States, Europe, and Australia, and we have developed a third-party distributor network to serve the hematology and oncology markets in 20 additional countries throughout the Middle East, Asia, and Latin America. The global capabilities within our sales, marketing and distribution organization distinguishes us from other companies of a similar size. With our international network we can reach physicians and their patients in more than 30 countries. With proven development and regulatory professionals and an experienced global commercialization team, we concentrate our resources on licensing, developing, and commercializing therapeutic products for the treatment of hematology and oncology patients. Through these efforts, we seek to provide greater therapeutic options to hematologists and oncologists with the ultimate goal of extending survival and improving patients’ quality of life.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Total funding: $105.0M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2002)
- Ticker: nasdaq:PHRM
- Website: pharmion.com
- Phone: 1(720) 564-9100
Industries & Categories
Biotechnology, Health Care, Medical, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pharmion-1687552 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.